{
    "1000001": {
        "text": "Patients with asthma and chronic obstructive pulmonary disease (COPD) often exhibit similar symptoms. Asthma patients frequently develop COPD as they age, both in cases of allergic and nonallergic asthma, requiring tailored approaches to treatment of these respiratory diseases. Human asthma and COPD patients require individualized treatment plans to manage symptoms of asthma effectively and to prevent respiratory abnormalities or complications. Inflammation and airway remodeling emphasizing the importance of targeted interventions for effective disease management.",
        "sentences": [
            "Patients with asthma and chronic obstructive pulmonary disease (COPD) often exhibit similar symptoms.",
            "Asthma patients frequently develop COPD as they age, both in cases of allergic and nonallergic asthma, requiring tailored approaches to treatment of these respiratory diseases.",
            "Human asthma and COPD patients require individualized treatment plans to manage symptoms of asthma effectively and to prevent respiratory abnormalities or complications.",
            "Inflammation and airway remodeling emphasizing the importance of targeted interventions for effective disease management."
        ],
        "annotations": [
            {
                "span": "14:20",
                "mention": "asthma"
            },
            {
                "span": "25:62",
                "mention": "chronic obstructive pulmonary disease"
            },
            {
                "span": "64:68",
                "mention": "COPD"
            },
            {
                "span": "102:108",
                "mention": "Asthma"
            },
            {
                "span": "137:141",
                "mention": "COPD"
            },
            {
                "span": "172:203",
                "mention": "allergic and nonallergic asthma"
            },
            {
                "span": "285:291",
                "mention": "asthma"
            },
            {
                "span": "296:300",
                "mention": "COPD"
            },
            {
                "span": "371:377",
                "mention": "asthma"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>asthma</entity> and <entity type=disease>chronic obstructive pulmonary disease (COPD)</entity> are often exhibited by patients with similar symptoms.\n```",
            " Text with markup:\n```\n<entity type=disease>Asthma</entity> patients frequently develop <entity type=disease>COPD</entity> as they age, both in cases of allergic and nonallergic <entity type=disease>asthma</entity>, requiring tailored approaches to treatment of these <entity type=disease>respiratory diseases</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Human asthma</entity> and <entity type=disease>COPD</entity> patients require individualized treatment plans to manage symptoms of <entity type=disease>asthma</entity> effectively and to prevent respiratory abnormalities or complications.\n```",
            " Text with markup:\n```\n<entity type=disease>Inflammation</entity> and airway remodeling emphasizing the importance of targeted interventions for effective <entity type=disease>disease management</entity>.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\nPatients with <entity type=disease>asthma</entity> and <entity type=disease>chronic obstructive pulmonary disease (COPD)</entity> often exhibit similar symptoms.\n```",
            " Text with markup:\n```\n<entity type=disease>Asthma</entity> patients frequently develop <entity type=disease>COPD</entity> as they age, both in cases of allergic and nonallergic <entity type=disease>asthma</entity>, requiring tailored approaches to treatment of these <entity type=disease>respiratory diseases</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Human asthma</entity> and <entity type=disease>COPD</entity> patients require individualized treatment plans to manage symptoms of <entity type=disease>asthma</entity> effectively and to prevent respiratory abnormalities or complications.\n```",
            " Text with markup:\n```\n<entity type=disease>Inflammation</entity> and airway remodeling emphasizing the importance of targeted interventions for effective <entity type=disease>disease management</entity>.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"asthma; chronic obstructive pulmonary disease (COPD)\"}\n```",
            " ```json:\n{\"diseases\": \"Asthma; COPD\"}\n```",
            " ```json:\n{\"diseases\": \"Human asthma; COPD; respiratory abnormalities; respiratory complications\"}\n```",
            " ```json:\n{\"diseases\": \"inflammation; airway remodeling\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"asthma; chronic obstructive pulmonary disease (COPD)\"}\n```",
            " ```json:\n{\"diseases\": \"Asthma; COPD\"}\n```",
            " ```json:\n{\"diseases\": \"Human asthma; COPD\"}\n```",
            " ```json:\n{\"diseases\": \"inflammation\"}\n```"
        ]
    },
    "1000002": {
        "text": "Type 1 and Type 2 diabetes represent different forms of diabetes mellitus (DM), with distinct pathophysiological mechanisms and symptoms. Patients with type 1 diabetes often develop complications such as ketoacidosis, while those with type 2 diabetes may face insulin resistance. Human diabetes, like mouse diabetes, need tailored interventions to manage blood sugar levels effectively. Glucose metabolism is critical biological processes in these diseases.",
        "sentences": [
            "Type 1 and Type 2 diabetes represent different forms of diabetes mellitus (DM), with distinct pathophysiological mechanisms and symptoms.",
            "Patients with type 1 diabetes often develop complications such as ketoacidosis, while those with type 2 diabetes may face insulin resistance.",
            "Human diabetes, like mouse diabetes, need tailored interventions to manage blood sugar levels effectively.",
            "Glucose metabolism is critical biological processes in these diseases."
        ],
        "annotations": [
            {
                "span": "0:26",
                "mention": "Type 1 and Type 2 diabetes"
            },
            {
                "span": "56:73",
                "mention": "diabetes mellitus"
            },
            {
                "span": "75:77",
                "mention": "DM"
            },
            {
                "span": "152:167",
                "mention": "type 1 diabetes"
            },
            {
                "span": "235:250",
                "mention": "type 2 diabetes"
            },
            {
                "span": "286:294",
                "mention": "diabetes"
            },
            {
                "span": "307:315",
                "mention": "diabetes"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Type 1 and Type 2 diabetes</entity> represent different forms of <entity type=disease>diabetes mellitus (DM)</entity>, with distinct pathophysiological mechanisms and symptoms.\n```",
            " Text with markup:\n```\n<entity type=disease>type 1 diabetes</entity> patients often develop complications such as <entity type=disease>ketoacidosis</entity>, while those with <entity type=disease>type 2 diabetes</entity> may face <entity type=disease>insulin resistance</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Human diabetes</entity>, like <entity type=disease>mouse diabetes</entity>, need tailored interventions to manage <entity type=disease>blood sugar levels</entity> effectively.\n```",
            " Text with markup:\n```\n<entity type=disease>Glucose metabolism</entity> is critical biological processes in these <entity type=disease>diseases</entity>.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Type 1 and Type 2 diabetes</entity> represent different forms of <entity type=disease>diabetes mellitus</entity> (<entity type=disease>DM</entity>), with distinct pathophysiological mechanisms and symptoms.\n```",
            " Text with markup:\n```\nPatients with <entity type=disease>type 1 diabetes</entity> often develop complications such as <entity type=disease>ketoacidosis</entity>, while those with <entity type=disease>type 2 diabetes</entity> may face <entity type=disease>insulin resistance</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Human diabetes</entity>, like <entity type=disease>mouse diabetes</entity>, need tailored interventions to manage blood sugar levels effectively.\n```",
            " Text with markup:\n```\n<entity type=disease>Glucose metabolism</entity> is critical biological processes in these <entity type=disease>diseases</entity>.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"Type 1 diabetes; Type 2 diabetes; diabetes mellitus\"}\n```",
            " ```json:\n{\"diseases\": \"type 1 diabetes; ketoacidosis; type 2 diabetes; insulin resistance\"}\n```",
            " ```json:\n{\"diseases\": \"Human diabetes; mouse diabetes\"}\n```",
            " ```json:\n{\"diseases\": \"unspecified diseases related to glucose metabolism\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"Type 1 diabetes; Type 2 diabetes; diabetes mellitus\"}\n```",
            " ```json:\n{\"diseases\": \"type 1 diabetes; type 2 diabetes\"}\n```",
            " ```json:\n{\"diseases\": \"Human diabetes\"}\n```",
            " ```json:\n{\"diseases\": \"diabetes; metabolic disorders\"}\n```"
        ]
    },
    "1000003": {
        "text": "Colorectal cancer (CRC), also known as bowel, colon, or rectal cancer. Early-stage and late-stage colorectal cancer present varying clinical symptoms that affect treatment choices. Patients with early-stage colorectal cancer might undergo surgery, while those with late-stage disease usually require chemotherapy or targeted therapies. Human colorectal cancer patients frequently exhibit KRAS mutations, which are important for treatment decisions in the case of colorectal cancer. Metastasis and angiogenesis complicate disease management.",
        "sentences": [
            "Colorectal cancer (CRC), also known as bowel, colon, or rectal cancer.",
            "Early-stage and late-stage colorectal cancer present varying clinical symptoms that affect treatment choices.",
            "Patients with early-stage colorectal cancer might undergo surgery, while those with late-stage disease usually require chemotherapy or targeted therapies.",
            "Human colorectal cancer patients frequently exhibit KRAS mutations, which are important for treatment decisions in the case of colorectal cancer.",
            "Metastasis and angiogenesis complicate disease management."
        ],
        "annotations": [
            {
                "span": "0:17",
                "mention": "Colorectal cancer"
            },
            {
                "span": "19:21",
                "mention": "CRC"
            },
            {
                "span": "39:69",
                "mention": "bowel, colon, or rectal cancer"
            },
            {
                "span": "71:115",
                "mention": "Early-stage and late-stage colorectal cancer"
            },
            {
                "span": "195:224",
                "mention": "early-stage colorectal cancer"
            },
            {
                "span": "342:359",
                "mention": "colorectal cancer"
            },
            {
                "span": "462:479",
                "mention": "colorectal cancer"
            },
            {
                "span": "481:491",
                "mention": "Metastasis"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Colorectal cancer (CRC)</entity>, also known as <entity type=disease>bowel</entity>, <entity type=disease>colon</entity>, or <entity type=disease>rectal cancer</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Early-stage and late-stage colorectal cancer</entity> present varying clinical symptoms that affect treatment choices.\n```",
            " Text with markup:\n```\nPatients with <entity type=disease>early-stage colorectal cancer</entity> might undergo surgery, while those with <entity type=disease>late-stage disease</entity> usually require chemotherapy or targeted therapies.\n```",
            " Text with markup:\n```\n<entity type=disease>Human colorectal cancer</entity> patients frequently exhibit <entity type=disease>KRAS mutations</entity>, which are important for treatment decisions in the case of <entity type=disease>colorectal cancer</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Metastasis</entity> and <entity type=disease>angiogenesis</entity> complicate disease management.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Colorectal cancer</entity> (<entity type=disease>CRC</entity>), also known as <entity type=disease>bowel</entity>, <entity type=disease>colon</entity>, or <entity type=disease>rectal cancer</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Early-stage and late-stage colorectal cancer</entity> present varying clinical symptoms that affect treatment choices.\n```",
            " Text with markup:\n```\n<entity type=disease>Patients with early-stage colorectal cancer</entity> might undergo surgery, while those with <entity type=disease>late-stage colorectal cancer</entity> usually require chemotherapy or targeted therapies.\n```",
            " Text with markup:\n```\n<entity type=disease>Human colorectal cancer</entity> patients frequently exhibit <entity type=disease>KRAS mutations</entity>, which are important for treatment decisions in the case of <entity type=disease>colorectal cancer</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Metastasis</entity> and <entity type=disease>angiogenesis</entity> complicate disease management.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"Colorectal cancer\"}\n```",
            " ```json:\n{\"diseases\": \"early-stage colorectal cancer; late-stage colorectal cancer\"}\n```",
            " ```json:\n{\"diseases\": \"early-stage colorectal cancer; late-stage colorectal cancer\"}\n```",
            " ```json:\n{\"diseases\": \"Human colorectal cancer; KRAS mutations\"}\n```",
            " ```json:\n{\"diseases\": \"metastasis; angiogenesis\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"Colorectal cancer; CRC\"}\n```",
            " ```json:\n{\"diseases\": \"early-stage colorectal cancer; late-stage colorectal cancer\"}\n```",
            " ```json:\n{\"diseases\": \"early-stage colorectal cancer; late-stage colorectal cancer\"}\n```",
            " ```json:\n{\"diseases\": \"Human colorectal cancer; KRAS mutations\"}\n```",
            " ```json:\n{\"diseases\": \"Metastasis; angiogenesis\"}\n```"
        ]
    },
    "1000004": {
        "text": "Similar treatment approaches can be shared by lung and bronchus cancer. The disease classification includes both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), as well as bronchus cancer. All of them involve tumorigenesis that influence treatment approaches. Patients with NSCLC often present with symptoms like cough and weight loss, while those with SCLC may exhibit more aggressive symptoms and require immediate intervention (no need for NSCLC patients). Targeted therapies for specific genetic mutations, such as EGFR and ALK, have significantly improved outcomes for human lung cancer patients. The prognosis of lung cancer can vary widely.",
        "sentences": [
            "Similar treatment approaches can be shared by lung and bronchus cancer.",
            "The disease classification includes both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), as well as bronchus cancer.",
            "All of them involve tumorigenesis that influence treatment approaches.",
            "Patients with NSCLC often present with symptoms like cough and weight loss, while those with SCLC may exhibit more aggressive symptoms and require immediate intervention (no need for NSCLC patients).",
            "Targeted therapies for specific genetic mutations, such as EGFR and ALK, have significantly improved outcomes for human lung cancer patients.",
            "The prognosis of lung cancer can vary widely."
        ],
        "annotations": [
            {
                "span": "46:70",
                "mention": "lung and bronchus cancer"
            },
            {
                "span": "113:139",
                "mention": "non-small cell lung cancer"
            },
            {
                "span": "141:146",
                "mention": "NSCLC"
            },
            {
                "span": "152:174",
                "mention": "small cell lung cancer"
            },
            {
                "span": "176:180",
                "mention": "SCLC"
            },
            {
                "span": "194:209",
                "mention": "bronchus cancer"
            },
            {
                "span": "296:301",
                "mention": "NSCLC"
            },
            {
                "span": "375:379",
                "mention": "SCLC"
            },
            {
                "span": "465:470",
                "mention": "NSCLC"
            },
            {
                "span": "573:584",
                "mention": "lung cancer"
            },
            {
                "span": "612:623",
                "mention": "lung cancer"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>lung</entity> and <entity type=disease>bronchus</entity> cancer.\n```",
            " The text with markup:\n```\nThe <entity type=disease>disease classification</entity> includes both <entity type=disease>non-small cell lung cancer (NSCLC)</entity> and <entity type=disease>small cell lung cancer (SCLC)</entity>, as well as <entity type=disease>bronchus cancer</entity>.\n```",
            " Text with markup:\n```\nAll of them involve <entity type=disease>tumorigenesis</entity> that influence treatment approaches.\n```",
            " Text with markup:\n```\nPatients with <entity type=disease>NSCLC</entity> often present with symptoms like <entity type=symptom>cough</entity> and weight loss, while those with <entity type=disease>SCLC</entity> may exhibit more aggressive symptoms and require immediate intervention (no need for <entity type=disease>NSCLC</entity> patients).\n```",
            " Text with markup:\n```\n<entity type=disease>human lung cancer</entity> patients have significantly improved outcomes with <entity type=disease>Targeted therapies</entity> for specific <entity type=disease>genetic mutations</entity>, such as <entity type=disease>EGFR</entity> and <entity type=disease>ALK</entity>.\n```",
            " The markup for the text provided would be:\n\n```\nThe <entity type=disease>lung cancer</entity> can vary widely.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Lung</entity> and <entity type=disease>bronchus cancer</entity> can share similar treatment approaches.\n```",
            " Text with markup:\n```\nThe disease classification includes both <entity type=disease>non-small cell lung cancer</entity> (<entity type=disease>NSCLC</entity>) and <entity type=disease>small cell lung cancer</entity> (<entity type=disease>SCLC</entity>) as well as <entity type=disease>bronchus cancer</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>All of them</entity> involve <entity type=disease>tumorigenesis</entity> that influence treatment approaches.\n```",
            " Text with markup:\n```\nPatients with <entity type=disease>NSCLC</entity> often present with symptoms like cough and weight loss, while those with <entity type=disease>SCLC</entity> may exhibit more aggressive symptoms and require immediate intervention.\n```",
            " Text with markup:\n```\n<entity type=disease>human lung cancer</entity> patients have significantly improved outcomes with <entity type=disease>Targeted therapies</entity> for specific <entity type=disease>genetic mutations</entity>, such as <entity type=disease>EGFR</entity> and <entity type=disease>ALK</entity>.\n```",
            " Text with markup:\n```\nThe <entity type=disease>prognosis of lung cancer</entity> can vary widely.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"lung cancer; bronchus cancer\"}\n```",
            " ```json:\n{\"diseases\": \"non-small cell lung cancer (NSCLC); small cell lung cancer (SCLC); bronchus cancer\"}\n```",
            " ```json:\n{\"diseases\": \"tumorigenesis\"}\n```",
            " ```json:\n{\"diseases\": \"NSCLC; SCLC\"}\n```",
            " ```json:\n{\"diseases\": \"lung cancer; EGFR mutation; ALK mutation\"}\n```",
            " ```json:\n{\"diseases\": \"lung cancer\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"lung cancer; bronchus cancer\"}\n```",
            " ```json:\n{\"diseases\": \"non-small cell lung cancer; NSCLC; small cell lung cancer; SCLC; bronchus cancer\"}\n```",
            " ```json:\n{\"diseases\": \"tumorigenesis\"}\n```",
            " ```json:\n{\"diseases\": \"NSCLC; SCLC\"}\n```",
            " ```json:\n{\"diseases\": \"human lung cancer; EGFR; ALK\"}\n```",
            " ```json:\n{\"diseases\": \"lung cancer\"}\n```"
        ]
    },
    "1000005": {
        "text": "The two prevalent cardiovascular conditions that can lead to significant morbidity and mortality are coronary artery and heart valve diseases. Coronary artery disease (CAD) is characterized by the narrowing of coronary arteries due to atherosclerosis, resulting in reduced blood flow to the heart muscle. Key symptoms of CAD include lipid metabolism, inflammation, and endothelial dysfunction. Patients may experience shortness of breath or fatigue. Mouse models of CAD are widely used to study the human CAD pathophysiology and to test new therapeutic strategies to prevent spontaneous coronary artery dissection (SCAD). In contrast, heart valve disease involves dysfunction of one or more heart valves, leading to symptoms such as heart murmurs, palpitations, and swelling.",
        "sentences": [
            "The two prevalent cardiovascular conditions that can lead to significant morbidity and mortality are coronary artery and heart valve diseases.",
            "Coronary artery disease (CAD) is characterized by the narrowing of coronary arteries due to atherosclerosis, resulting in reduced blood flow to the heart muscle.",
            "Key symptoms of CAD include lipid metabolism, inflammation, and endothelial dysfunction.",
            "Patients may experience shortness of breath or fatigue.",
            "Mouse models of CAD are widely used to study the human CAD pathophysiology and to test new therapeutic strategies to prevent spontaneous coronary artery dissection (SCAD).",
            "In contrast, heart valve disease involves dysfunction of one or more heart valves, leading to symptoms such as heart murmurs, palpitations, and swelling."
        ],
        "annotations": [
            {
                "span": "101:141",
                "mention": "coronary artery and heart valve diseases"
            },
            {
                "span": "143:166",
                "mention": "Coronary artery disease"
            },
            {
                "span": "168:171",
                "mention": "CAD"
            },
            {
                "span": "235:250",
                "mention": "atherosclerosis"
            },
            {
                "span": "321:324",
                "mention": "CAD"
            },
            {
                "span": "466:469",
                "mention": "CAD"
            },
            {
                "span": "505:508",
                "mention": "CAD"
            },
            {
                "span": "575:613",
                "mention": "spontaneous coronary artery dissection"
            },
            {
                "span": "615:619",
                "mention": "SCAD"
            },
            {
                "span": "635:654",
                "mention": "heart valve disease"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\nThe <entity type=disease>coronary artery</entity> and <entity type=disease>heart valve</entity> diseases are the two prevalent <entity type=disease>cardiovascular conditions</entity> that can lead to significant morbidity and mortality.\n```",
            " Text with markup:\n```\nCoronary artery disease (<entity type=disease>CAD</entity>) is characterized by the narrowing of coronary arteries due to <entity type=disease>atherosclerosis</entity>, resulting in reduced blood flow to the heart muscle.\n```",
            " Text with markup:\n```\n<entity type=disease>CAD</entity> key symptoms include <entity type=disease>lipid metabolism</entity>, inflammation, and <entity type=disease>endothelial dysfunction</entity>.\n```",
            " Text with markup:\n```\nPatients may experience <entity type=disease>shortness of breath</entity> or <entity type=disease>fatigue</entity>.\n```",
            " Text with markup:\n```\nMouse models of <entity type=disease>CAD</entity> are widely used to study the human <entity type=disease>CAD pathophysiology</entity> and to test new therapeutic strategies to prevent spontaneous <entity type=disease>coronary artery dissection (SCAD)</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>heart valve disease</entity> involves dysfunction of one or more <entity type=disease>heart valves</entity>, leading to symptoms such as heart murmurs, <entity type=disease>palpitations</entity>, and swelling.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\nThe two prevalent <entity type=disease>cardiovascular conditions</entity> that can lead to significant morbidity and mortality are <entity type=disease>coronary artery disease</entity> and <entity type=disease>heart valve disease</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Coronary artery disease</entity> (<entity type=disease>CAD</entity>) is characterized by the narrowing of <entity type=disease>coronary arteries</entity> due to atherosclerosis, resulting in reduced blood flow to the heart muscle.\n```",
            " Text with markup:\n```\n<entity type=disease>CAD</entity> includes key symptoms of <entity type=disease>lipid metabolism</entity>, inflammation, and <entity type=disease>endothelial dysfunction</entity>.\n```",
            " Text with markup:\n```\nPatients may experience <entity type=disease>shortness of breath</entity> or <entity type=disease>fatigue</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>spontaneous coronary artery dissection (SCAD)</entity>\n```",
            " Text with markup:\n```\n<entity type=disease>Heart valve disease</entity> involves dysfunction of one or more <entity type=disease>heart valves</entity>, leading to symptoms such as heart murmurs, palpitations, and swelling.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"coronary artery diseases; heart valve diseases\"}\n```",
            " ```json:\n{\"diseases\": \"Coronary artery disease (CAD)\"}\n```",
            " ```json:\n{\"diseases\": \"CAD; lipid metabolism disorders; inflammation; endothelial dysfunction\"}\n```",
            " ```json:\n{\"diseases\": \"shortness of breath; fatigue\"}\n```",
            " ```json:\n{\"diseases\": \"spontaneous coronary artery dissection (SCAD)}\n```",
            " ```json:\n{\"diseases\": \"heart valve disease; heart murmurs; palpitations; swelling\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"coronary artery diseases; heart valve diseases\"}\n```",
            " ```json:\n{\"diseases\": \"Coronary artery disease (CAD); atherosclerosis\"}\n```",
            " ```json:\n{\"diseases\": \"CAD; lipid metabolism\"}\n```",
            " ```json:\n{\"diseases\": \"shortness of breath; fatigue\"}\n```",
            " ```json:\n{\"diseases\": \"spontaneous coronary artery dissection (SCAD)\"}\n```",
            " ```json:\n{\"diseases\": \"heart valve disease\"}\n```"
        ]
    },
    "1000006": {
        "text": "Parkinson's disease (PD) and Huntington's disease (HD) are neurodegenerative disorders with distinct but sometimes overlapping clinical features. Parkinson's disease is primarily characterized by motor symptoms such as bradykinesia, rigidity, and tremor, while Huntington's disease symptoms involves progressive motor dysfunction as well as cognitive decline. Human Parkinson's and Huntington's diseases patients require tailored treatments, including dopamine replacement therapies for PD and symptomatic management both for HD and PD. Both diseases are linked to the dysfunction of basal ganglia pathways, leading to movement abnormalities. Juvenile Parkinson's disease (JPD) is a rare form of Parkinson's that occurs in younger patients. Apoptosis, mitochondrial dysfunction, and protein aggregation play important roles in the progression of these diseases.",
        "sentences": [
            "Parkinson's disease (PD) and Huntington's disease (HD) are neurodegenerative disorders with distinct but sometimes overlapping clinical features.",
            "Parkinson's disease is primarily characterized by motor symptoms such as bradykinesia, rigidity, and tremor, while Huntington's disease symptoms involves progressive motor dysfunction as well as cognitive decline.",
            "Human Parkinson's and Huntington's diseases patients require tailored treatments, including dopamine replacement therapies for PD and symptomatic management both for HD and PD.",
            "Both diseases are linked to the dysfunction of basal ganglia pathways, leading to movement abnormalities.",
            "Juvenile Parkinson's disease (JPD) is a rare form of Parkinson's that occurs in younger patients.",
            "Apoptosis, mitochondrial dysfunction, and protein aggregation play important roles in the progression of these diseases."
        ],
        "annotations": [
            {
                "span": "0:19",
                "mention": "Parkinson's disease"
            },
            {
                "span": "21:23",
                "mention": "PD"
            },
            {
                "span": "29:49",
                "mention": "Huntington's disease"
            },
            {
                "span": "51:53",
                "mention": "HD"
            },
            {
                "span": "146:165",
                "mention": "Parkinson's disease"
            },
            {
                "span": "261:281",
                "mention": "Huntington's disease"
            },
            {
                "span": "366:404",
                "mention": "Parkinson's and Huntington's diaseases"
            },
            {
                "span": "488:490",
                "mention": "PD"
            },
            {
                "span": "527:529",
                "mention": "HD"
            },
            {
                "span": "534:536",
                "mention": "PD"
            },
            {
                "span": "644:672",
                "mention": "Juvenile Parkinson's disease"
            },
            {
                "span": "674:677",
                "mention": "JPD"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Parkinson's disease (PD)</entity> and <entity type=disease>Huntington's disease (HD)</entity> are neurodegenerative disorders with distinct but sometimes overlapping clinical features.\n```",
            " Text with markup:\n```\n<entity type=disease>Parkinson's disease</entity> is primarily characterized by motor symptoms such as <entity type=disease>bradykinesia</entity>, rigidity, and tremor, while <entity type=disease>Huntington's disease</entity> symptoms involves progressive motor dysfunction as well as cognitive decline.\n```",
            " Text with markup:\n```\n<entity type=disease>Human Parkinson's</entity> and <entity type=disease>Huntington's diseases</entity> patients require tailored treatments, including dopamine replacement therapies for <entity type=disease>Parkinson's disease</entity> (PD) and symptomatic management both for <entity type=disease>Huntington's disease</entity> and <entity type=disease>Parkinson's disease</entity>.\n```",
            " Text with markup:\n```\nBoth <entity type=disease>diseases</entity> are linked to the dysfunction of basal ganglia pathways, leading to <entity type=disease>movement abnormalities</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Juvenile Parkinson's disease (JPD)</entity> is a rare form of Parkinson's that occurs in younger patients.\n```",
            " Text with markup:\n```\n<entity type=disease>Apoptosis</entity>, <entity type=disease>mitochondrial dysfunction</entity>, and <entity type=disease>protein aggregation</entity> play important roles in the progression of these <entity type=disease>diseases</entity>.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Parkinson's disease</entity> (<entity type=disease>PD</entity>) and <entity type=disease>Huntington's disease</entity> (<entity type=disease>HD</entity>) are neurodegenerative disorders with distinct but sometimes overlapping clinical features.\n```",
            " Text with markup:\n```\n<entity type=disease>Parkinson's disease</entity> is primarily characterized by motor symptoms such as bradykinesia, rigidity, and tremor, while <entity type=disease>Huntington's disease</entity> symptoms involve progressive motor dysfunction as well as cognitive decline.\n```",
            " Text with markup:\n```\n<entity type=disease>Human Parkinson's</entity> and <entity type=disease>Huntington's</entity> diseases patients require tailored treatments, including dopamine replacement therapies for <entity type=disease>PD</entity> and symptomatic management both for <entity type=disease>HD</entity> and <entity type=disease>PD</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Both diseases</entity> are linked to the dysfunction of <entity type=disease>basal ganglia pathways</entity>, leading to movement <entity type=disease>abnormalities</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Juvenile Parkinson's disease</entity> (<entity type=disease>JPD</entity>) is a rare form of <entity type=disease>Parkinson's</entity> that occurs in younger patients.\n```",
            " Text with markup:\n```\n<entity type=disease>Apoptosis</entity>, <entity type=disease>mitochondrial dysfunction</entity>, and <entity type=disease>protein aggregation</entity> play important roles in the progression of these <entity type=disease>diseases</entity>.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"Parkinson's disease; Huntington's disease\"}\n```",
            " ```json:\n{\"diseases\": \"Parkinson's disease; Huntington's disease\"}\n```",
            " ```json:\n{\"diseases\": \"Human Parkinson's disease; Huntington's disease\"}\n```",
            " ```json:\n{\"diseases\": \"basal ganglia diseases; movement abnormalities\"}\n```",
            " ```json:\n{\"diseases\": \"Juvenile Parkinson's disease (JPD)\"}\n```",
            " ```json:\n{\"diseases\": \"Apoptosis, mitochondrial dysfunction, protein aggregation diseases\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"Parkinson's disease; Huntington's disease\"}\n```",
            " ```json:\n{\"diseases\": \"Parkinson's disease; Huntington's disease\"}\n```",
            " ```json:\n{\"diseases\": \"Parkinson's diseases; Huntington's diseases\"}\n```",
            " ```json:\n{\"diseases\": \"dysfunction of basal ganglia pathways; Parkinson's disease, Huntington's disease\"}\n```",
            " ```json:\n{\"diseases\": \"Juvenile Parkinson's disease; Parkinson's\"}\n```",
            " ```json:\n{\"diseases\": \"Apoptosis; mitochondrial dysfunction; protein aggregation\"}\n```"
        ]
    },
    "1000007": {
        "text": "Autoimmune diseases like systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE) present with overlapping symptoms, including joint pain and inflammation. Multiple organs such as the skin, kidneys, and cardiovascular system can be affected by systemic lupus and cutaneous lupus erythematosus. Treatment for SLE and CLE focuses on targeted therapies, including the use of immunosuppressants to alleviate symptoms and prevent disease progression. SLE has also been observed in animals, particularly in dogs, where dog SLE can manifest as skin lesions and kidney dysfunction. The progression of both SLE and CLE involves T-cell activation, cytokine release, and autoantibody production.",
        "sentences": [
            "Autoimmune diseases like systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE) present with overlapping symptoms, including joint pain and inflammation.",
            "Multiple organs such as the skin, kidneys, and cardiovascular system can be affected by systemic lupus and cutaneous lupus erythematosus.",
            "Treatment for SLE and CLE focuses on targeted therapies, including the use of immunosuppressants to alleviate symptoms and prevent disease progression.",
            "SLE has also been observed in animals, particularly in dogs, where dog SLE can manifest as skin lesions and kidney dysfunction.",
            "The progression of both SLE and CLE involves T-cell activation, cytokine release, and autoantibody production."
        ],
        "annotations": [
            {
                "span": "0:19",
                "mention": "Autoimmune diseases"
            },
            {
                "span": "25:53",
                "mention": "systemic lupus erythematosus"
            },
            {
                "span": "55:58",
                "mention": "SLE"
            },
            {
                "span": "64:93",
                "mention": "cutaneous lupus erythematosus"
            },
            {
                "span": "95:98",
                "mention": "CLE"
            },
            {
                "span": "262:310",
                "mention": "systemic lupus and cutaneous lupus erythematosus"
            },
            {
                "span": "326:329",
                "mention": "SLE"
            },
            {
                "span": "334:337",
                "mention": "CLE"
            },
            {
                "span": "464:467",
                "mention": "SLE"
            },
            {
                "span": "535:538",
                "mention": "SLE"
            },
            {
                "span": "616:619",
                "mention": "SLE"
            },
            {
                "span": "624:627",
                "mention": "CLE"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Autoimmune diseases</entity> like systemic lupus erythematosus (<entity type=disease>SLE</entity>) and cutaneous lupus erythematosus (<entity type=disease>CLE</entity>) present with overlapping symptoms, including joint pain and inflammation.\n```",
            " Text with markup:\n```\nMultiple organs such as the <entity type=disease>skin</entity>, <entity type=disease>kidneys</entity>, and <entity type=disease>cardiovascular system</entity> can be affected by <entity type=disease>systemic lupus</entity> and <entity type=disease>cutaneous lupus erythematosus</entity>.\n```",
            " Text with markup:\n```\nTreatment for <entity type=disease>SLE</entity> and <entity type=disease>CLE</entity> focuses on targeted therapies, including the use of immunosuppressants to alleviate symptoms and prevent disease progression.\n```",
            " Text with markup:\n```\n<entity type=disease>SLE</entity> has also been observed in animals, particularly in dogs, where <entity type=disease>dog SLE</entity> can manifest as skin lesions and kidney dysfunction.\n```",
            " Text with markup:\n```\nThe <entity type=disease>progression</entity> of both <entity type=disease>SLE</entity> and <entity type=disease>CLE</entity> involves T-cell activation, cytokine release, and autoantibody production.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Autoimmune diseases</entity> like <entity type=disease>systemic lupus erythematosus</entity> (<entity type=disease>SLE</entity>) and <entity type=disease>cutaneous lupus erythematosus</entity> (<entity type=disease>CLE</entity>) present with overlapping symptoms, including joint pain and inflammation.\n```",
            " Text with markup:\n```\nMultiple organs such as the <entity type=disease>skin</entity>, <entity type=disease>kidneys</entity>, and <entity type=disease>cardiovascular system</entity> can be affected by <entity type=disease>systemic lupus</entity> and <entity type=disease>cutaneous lupus erythematosus</entity>.\n```",
            " Text with markup:\n```\nTreatment for <entity type=disease>Systemic lupus erythematosus</entity> (<entity type=disease>SLE</entity>) and <entity type=disease>Cutaneous lupus erythematosus</entity> (<entity type=disease>CLE</entity>) focuses on targeted therapies, including the use of immunosuppressants to alleviate symptoms and prevent disease progression.\n```",
            " Text with markup:\n```\n<entity type=disease>SLE</entity> has also been observed in animals, particularly in dogs, where <entity type=disease>dog SLE</entity> can manifest as skin lesions and kidney dysfunction.\n```",
            " Text with markup:\n```\nThe progression of both <entity type=disease>Systemic lupus erythematosus</entity> (<entity type=disease>SLE</entity>) and <entity type=disease>Cutaneous lupus erythematosus</entity> (<entity type=disease>CLE</entity>) involves T-cell activation, cytokine release, and autoantibody production.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"systemic lupus erythematosus (SLE); cutaneous lupus erythematosus (CLE)}\n```",
            " ```json:\n{\"diseases\": \"systemic lupus; cutaneous lupus erythematosus\"}\n```",
            " ```json:\n{\"diseases\": \"SLE; CLE\"}\n```",
            " ```json:\n{\"diseases\": \"SLE; skin lesions; kidney dysfunction\"}\n```",
            " ```json:\n{\"diseases\": \"SLE; CLE\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"systemic lupus erythematosus; SLE; cutaneous lupus erythematosus; CLE\"}\n```",
            " ```json:\n{\"diseases\": \"systemic lupus; cutaneous lupus erythematosus\"}\n```",
            " ```json:\n{\"diseases\": \"SLE; CLE\"}\n```",
            " ```json:\n{\"diseases\": \"SLE; dog SLE\"}\n```",
            " ```json:\n{\"diseases\": \"SLE; CLE\"}\n```"
        ]
    },
    "1000008": {
        "text": "Alzheimer's disease (AD), frontotemporal dementia (FTD), and young-onset dementia (YOD) are major forms of dementia with distinct neurodegenerative patterns. AD primarily involves memory loss due to synaptic dysfunction and neurodegeneration in the hippocampus, while the characteristics of frontotemporal and young-onset dementia are marked by personality changes and language dysfunction. YOD includes early-onset forms of both AD and FTD, therefore, YOD is more challenging to be recognized. FTD involves protein inclusions like TDP-43, leading to frontal and temporal lobe atrophy. Animal research, particularly with transgenic mice, has provided key insights into these pathologies, aiding the development of potential treatments. In case of mice AD early intervention, lifestyle changes, and medications appeared to be critical for managing the disease complications.",
        "sentences": [
            "Alzheimer's disease (AD), frontotemporal dementia (FTD), and young-onset dementia (YOD) are major forms of dementia with distinct neurodegenerative patterns.",
            "AD primarily involves memory loss due to synaptic dysfunction and neurodegeneration in the hippocampus, while the characteristics of frontotemporal and young-onset dementia are marked by personality changes and language dysfunction.",
            "YOD includes early-onset forms of both AD and FTD, therefore, YOD is more challenging to be recognized.",
            "FTD involves protein inclusions like TDP-43, leading to frontal and temporal lobe atrophy.",
            "Animal research, particularly with transgenic mice, has provided key insights into these pathologies, aiding the development of potential treatments.",
            "In case of mice AD early intervention, lifestyle changes, and medications appeared to be critical for managing the disease complications."
        ],
        "annotations": [
            {
                "span": "0:19",
                "mention": "Alzheimer's disease"
            },
            {
                "span": "21:23",
                "mention": "AD"
            },
            {
                "span": "26:49",
                "mention": "frontotemporal dementia"
            },
            {
                "span": "51:54",
                "mention": "FTD"
            },
            {
                "span": "61:81",
                "mention": "young-onset dementia"
            },
            {
                "span": "83:86",
                "mention": "YOD"
            },
            {
                "span": "107:115",
                "mention": "dementia"
            },
            {
                "span": "158:160",
                "mention": "AD"
            },
            {
                "span": "291:330",
                "mention": "frontotemporal and young-onset dementia"
            },
            {
                "span": "391:394",
                "mention": "YOD"
            },
            {
                "span": "430:432",
                "mention": "AD"
            },
            {
                "span": "437:440",
                "mention": "FTD"
            },
            {
                "span": "453:456",
                "mention": "YOD"
            },
            {
                "span": "495:498",
                "mention": "FTD"
            },
            {
                "span": "752:754",
                "mention": "AD"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Alzheimer's disease</entity> (AD), <entity type=disease>frontotemporal dementia</entity> (FTD), and young-onset dementia (YOD) are major forms of <entity type=disease>dementia</entity> with distinct neurodegenerative patterns.\n```",
            " Text with markup:\n```\n<entity type=disease>AD</entity> primarily involves memory loss due to synaptic dysfunction and neurodegeneration in the <entity type=disease>hippocampus</entity>, while the characteristics of <entity type=disease>frontotemporal and young-onset dementia</entity> are marked by personality changes and language dysfunction.\n```",
            " Text with markup:\n```\n<entity type=disease>YOD</entity> includes early-onset forms of both <entity type=disease>AD</entity> and <entity type=disease>FTD</entity>, therefore, <entity type=disease>YOD</entity> is more challenging to be recognized.\n```",
            " Text with markup:\n```\n<entity type=disease>FTD</entity> involves protein inclusions like TDP-43, leading to frontal and temporal lobe <entity type=disease>atrophy</entity>.\n```",
            " Text with markup:\n```\nAnimal research, particularly with <entity type=disease>transgenic mice</entity>, has provided key insights into these <entity type=disease>pathologies</entity>, aiding the development of potential treatments.\n```",
            " Text with markup:\n```\nIn case of mice AD early intervention, lifestyle changes, and medications appeared to be critical for managing the <entity type=disease>disease complications</entity>.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Alzheimer's disease</entity> (<entity type=disease>AD</entity>), <entity type=disease>frontotemporal dementia</entity> (<entity type=disease>FTD</entity>), and <entity type=disease>young-onset dementia</entity> (<entity type=disease>YOD</entity>) are major forms of dementia with distinct neurodegenerative patterns.\n```",
            " Text with markup:\n```\n<entity type=disease>AD</entity> primarily involves memory loss due to synaptic dysfunction and neurodegeneration in the <entity type=disease>hippocampus</entity>, while the characteristics of <entity type=disease>frontotemporal dementia</entity> and <entity type=disease>young-onset dementia</entity> are marked by personality changes and language dysfunction.\n```",
            " Text with markup:\n```\n<entity type=disease>YOD</entity> includes early-onset forms of both <entity type=disease>AD</entity> and <entity type=disease>FTD</entity>, therefore, <entity type=disease>YOD</entity> is more challenging to be recognized.\n```",
            " Text with markup:\n```\n<entity type=disease>FTD</entity> involves protein inclusions like <entity type=disease>TDP-43</entity>, leading to frontal and temporal lobe <entity type=disease>atrophy</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Animal research</entity>, particularly with <entity type=disease>transgenic mice</entity>, has provided key insights into these <entity type=disease>pathologies</entity>, aiding the development of potential treatments.\n```",
            " Text with markup:\n```\n<entity type=disease>Alzheimer's disease</entity> (<entity type=disease>AD</entity>) early intervention, lifestyle changes, and medications appeared to be critical for managing the disease complications.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"Alzheimer's disease; frontotemporal dementia; young-onset dementia\"}\n```",
            " ```json:\n{\"diseases\": \"Alzheimer's disease; frontotemporal dementia; young-onset dementia\"}\n```",
            " ```json:\n{\"diseases\": \"Alzheimer's disease (AD), Frontotemporal dementia (FTD), early-onset forms of both\"}\n```",
            " ```json:\n{\"diseases\": \"FTD; Frontal and Temporal Lobe Atrophy\"}\n```",
            " ```json:\n{\"diseases\": \"pathologies\"}\n```",
            " ```json:\n{\"diseases\": \"AD\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"Alzheimer's disease; frontotemporal dementia; young-onset dementia\"}\n```",
            " ```json:\n{\"diseases\": \"Alzheimer's disease; frontotemporal dementia; young-onset dementia\"}\n```",
            " ```json:\n{\"diseases\": \"Alzheimer's disease; Frontotemporal dementia\"}\n```",
            " ```json:\n{\"diseases\": \"FTD; TDP-43\"}\n```",
            " ```json:\n{\"diseases\": \"these pathologies\"}\n```",
            " ```json:\n{\"diseases\": \"Alzheimer's disease\"}\n```"
        ]
    },
    "1000009": {
        "text": "Atopic and seborrheic dermatitis are common inflammatory skin conditions affecting millions worldwide. Atopic Dermatitis (AD), known also as eczema, is characterized by dry, itchy skin due to a combination of genetic predisposition and environmental triggers. It involves an overactive immune response, particularly a Th2 response, leading to inflammation and a compromised skin barrier. Treatment often includes moisturizers and topical corticosteroids. Seborrheic Dermatitis (SD) features red, greasy patches, mainly caused by the overgrowth of Malassezia yeast and sebaceous gland activity. This condition also involves immune dysregulation and is treated with antifungal creams and medicated shampoos. Both conditions share underlying mechanisms of immune dysregulation and inflammation, impacting the quality of life for many individuals. Human SD forms can often lead to complications in AD, particularly resulting in AD irritations on the face and neck.",
        "sentences": [
            "Atopic and seborrheic dermatitis are common inflammatory skin conditions affecting millions worldwide.",
            "Atopic Dermatitis (AD), known also as eczema, is characterized by dry, itchy skin due to a combination of genetic predisposition and environmental triggers.",
            "It involves an overactive immune response, particularly a Th2 response, leading to inflammation and a compromised skin barrier.",
            "Treatment often includes moisturizers and topical corticosteroids.",
            "Seborrheic Dermatitis (SD) features red, greasy patches, mainly caused by the overgrowth of Malassezia yeast and sebaceous gland activity.",
            "This condition also involves immune dysregulation and is treated with antifungal creams and medicated shampoos.",
            "Both conditions share underlying mechanisms of immune dysregulation and inflammation, impacting the quality of life for many individuals.",
            "Human SD forms can often lead to complications in AD, particularly resulting in AD irritations on the face and neck."
        ],
        "annotations": [
            {
                "span": "0:32",
                "mention": "Atopic and seborrheic dermatitis"
            },
            {
                "span": "103:120",
                "mention": "Atopic Dermatitis"
            },
            {
                "span": "122:124",
                "mention": "AD"
            },
            {
                "span": "141:147",
                "mention": "eczema"
            },
            {
                "span": "455:476",
                "mention": "Seborrheic Dermatitis"
            },
            {
                "span": "478:480",
                "mention": "SD"
            },
            {
                "span": "850:852",
                "mention": "SD"
            },
            {
                "span": "894:896",
                "mention": "AD"
            },
            {
                "span": "924:926",
                "mention": "AD"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Atopic</entity> and <entity type=disease>seborrheic dermatitis</entity> are common inflammatory <entity type=disease>skin conditions</entity> affecting millions worldwide.\n```",
            " Text with markup:\n```\n<entity type=disease>Atopic Dermatitis (AD)</entity>, known also as eczema, is characterized by dry, itchy skin due to a combination of genetic predisposition and environmental triggers.\n```",
            " Text with markup:\n```\nIt involves an overactive <entity type=disease>immune response</entity>, particularly a Th2 response, leading to inflammation and a compromised <entity type=disease>skin barrier</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Treatment</entity> often includes <entity type=disease>moisturizers</entity> and topical <entity type=disease>corticosteroids</entity>.\n```",
            " Text with markup:\n```\nSeborrheic Dermatitis (<entity type=disease>SD</entity>) features red, greasy patches, mainly caused by the overgrowth of <entity type=disease>Malassezia yeast</entity> and sebaceous gland activity.\n```",
            " Text with markup:\n```\nThis condition also involves <entity type=disease>immune dysregulation</entity> and is treated with <entity type=disease>antifungal creams</entity> and medicated shampoos.\n```",
            " Text with markup:\n```\nBoth conditions share underlying mechanisms of <entity type=disease>immune dysregulation</entity> and <entity type=disease>inflammation</entity>, impacting the quality of life for many individuals.\n```",
            " Text with markup:\n```\n<entity type=disease>Human SD</entity> forms can often lead to complications in AD, particularly resulting in <entity type=disease>AD irritations</entity> on the face and neck.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Atopic dermatitis</entity> and <entity type=disease>seborrheic dermatitis</entity> are common inflammatory <entity type=disease>skin conditions</entity> affecting millions worldwide.\n```",
            " Text with markup:\n```\n<entity type=disease>Atopic Dermatitis (AD)</entity>, known also as <entity type=disease>eczema</entity>, is characterized by dry, itchy skin due to a combination of genetic predisposition and environmental triggers.\n```",
            " Text with markup:\n```\n<entity type=disease>It involves an overactive immune response, particularly a Th2 response, leading to inflammation and a compromised skin barrier.</entity>\n```\n\nIn this case, the text does not explicitly mention a specific disease, but it describes an overactive immune response, which can be associated with various diseases. However, since the text does not specify a particular disease, it is best to mark the entire text as a single disease entity to maintain consistency with the provided rules.",
            " Text with markup:\n```\n<entity type=disease>Treatment</entity> often includes <entity type=disease>moisturizers</entity> and topical <entity type=disease>corticosteroids</entity>.\n```",
            " Text with markup:\n```\n<entity type=disease>Seborrheic Dermatitis</entity> (<entity type=disease>SD</entity>) features red, greasy patches, mainly caused by the overgrowth of <entity type=disease>Malassezia yeast</entity> and sebaceous gland activity.\n```",
            " Text with markup:\n```\nThis condition also involves <entity type=disease>immune dysregulation</entity> and is treated with <entity type=disease>antifungal creams</entity> and medicated shampoos.\n```",
            " Text with markup:\n```\n<entity type=disease>Both conditions</entity> share underlying mechanisms of <entity type=disease>immune dysregulation</entity> and <entity type=disease>inflammation</entity>, impacting the quality of life for many individuals.\n```",
            " Text with markup:\n```\n<entity type=disease>Human SD</entity> forms can often lead to complications in <entity type=disease>AD</entity>, particularly resulting in <entity type=disease>AD irritations</entity> on the face and neck.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"atopic dermatitis; seborrheic dermatitis\"}\n```",
            " ```json:\n{\"diseases\": \"Atopic Dermatitis; eczema\"}\n```",
            " ```json:\n{\"diseases\": \"Th2 response related diseases; skin barrier compromised diseases\"}\n```",
            " ```json:\n{\"diseases\": \"No specific diseases mentioned in the text\"}\n```",
            " ```json:\n{\"diseases\": \"Seborrheic Dermatitis\"}\n```",
            " ```json:\n{\"diseases\": \"immune dysregulation\"}\n```",
            " ```json:\n{\"diseases\": \"immune dysregulation; inflammation\"}\n```",
            " ```json:\n{\"diseases\": \"AD irritations on the face and neck\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"Atopic dermatitis; seborrheic dermatitis\"}\n```",
            " ```json:\n{\"diseases\": \"Atopic Dermatitis; eczema\"}\n```",
            " ```json:\n{\"diseases\": \"Th2 response\"}\n```",
            " ```json:\n{\"diseases\": \"None\"}\n```",
            " ```json:\n{\"diseases\": \"Seborrheic Dermatitis; SD\"}\n```",
            " ```json:\n{\"diseases\": \"immune dysregulation\"}\n```",
            " ```json:\n{\"diseases\": \"immune dysregulation; inflammation\"}\n```",
            " ```json:\n{\"diseases\": \"Human SD; AD\"}\n```"
        ]
    },
    "1000010": {
        "text": "Celiac or Coeliac disease and non-celiac gluten sensitivity (NCGS) are conditions associated with adverse responses to gluten. Celiac disease is an autoimmune disorder characterized by the activation of tissue transglutaminase (tTG) antibodies, leading to inflammation and villous atrophy in the small intestine when gluten is consumed. This results in malabsorption of nutrients, anemia, and other complications. Conversely, NCGS does not involve an autoimmune response or intestinal damage, but still produces gastrointestinal symptoms such as bloating and abdominal pain. In animals, NCGS has been observed in dogs, resulting in similar gastrointestinal distress, but it does not exhibit the same autoimmune pathology as seen in human NCGS. While patients with celiac disease require a strict gluten-free diet to prevent complications, individuals with NCGS often benefit from a gluten-reduced diet without the need for complete avoidance.",
        "sentences": [
            "Celiac or Coeliac disease and non-celiac gluten sensitivity (NCGS) are conditions associated with adverse responses to gluten.",
            "Celiac disease is an autoimmune disorder characterized by the activation of tissue transglutaminase (tTG) antibodies, leading to inflammation and villous atrophy in the small intestine when gluten is consumed.",
            "This results in malabsorption of nutrients, anemia, and other complications.",
            "Conversely, NCGS does not involve an autoimmune response or intestinal damage, but still produces gastrointestinal symptoms such as bloating and abdominal pain.",
            "In animals, NCGS has been observed in dogs, resulting in similar gastrointestinal distress, but it does not exhibit the same autoimmune pathology as seen in human NCGS.",
            "While patients with celiac disease require a strict gluten-free diet to prevent complications, individuals with NCGS often benefit from a gluten-reduced diet without the need for complete avoidance."
        ],
        "annotations": [
            {
                "span": "0:25",
                "mention": "Celiac or Coeliac disease"
            },
            {
                "span": "30:59",
                "mention": "non-celiac gluten sensitivity"
            },
            {
                "span": "61:65",
                "mention": "NCGS"
            },
            {
                "span": "127:141",
                "mention": "Celiac disease"
            },
            {
                "span": "426:430",
                "mention": "NCGS"
            },
            {
                "span": "587:591",
                "mention": "NCGS"
            },
            {
                "span": "738:742",
                "mention": "NCGS"
            },
            {
                "span": "764:778",
                "mention": "celiac disease"
            },
            {
                "span": "856:860",
                "mention": "NCGS"
            }
        ],
        "response_markup_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Celiac or Coeliac disease</entity> and <entity type=disease>non-celiac gluten sensitivity (NCGS)</entity> are conditions associated with adverse responses to gluten.\n```",
            " Text with markup:\n```\n<entity type=disease>Celiac disease</entity> is an autoimmune disorder characterized by the activation of <entity type=disease>tissue transglutaminase (tTG)</entity> antibodies, leading to inflammation and villous atrophy in the small intestine when <entity type=disease>gluten</entity> is consumed.\n```",
            " Text with markup:\n```\nThis results in <entity type=disease>malabsorption of nutrients</entity>, <entity type=disease>anemia</entity>, and other complications.\n```",
            " Text with markup:\n```\nConversely, <entity type=disease>NCGS</entity> does not involve an autoimmune response or intestinal damage, but still produces gastrointestinal symptoms such as bloating and <entity type=disease>abdominal pain</entity>.\n```",
            " Text with markup:\n```\nIn animals, <entity type=disease>NCGS</entity> has been observed in dogs, resulting in similar gastrointestinal distress, but it does not exhibit the same autoimmune pathology as seen in human <entity type=disease>NCGS</entity>.\n```",
            " Text with markup:\n```\nWhile patients with <entity type=disease>celiac disease</entity> require a strict gluten-free diet to prevent complications, individuals with NCGS often benefit from a gluten-reduced diet without the need for complete avoidance.\n```"
        ],
        "response_markup_rules_mistral0.3": [
            " Text with markup:\n```\n<entity type=disease>Celiac or Coeliac disease</entity> and non-<entity type=disease>celiac gluten sensitivity</entity> (<entity type=disease>NCGS</entity>) are conditions associated with adverse responses to gluten.\n```",
            " Text with markup:\n```\n<entity type=disease>Celiac disease</entity> is an <entity type=disease>autoimmune disorder</entity> characterized by the activation of <entity type=disease>tissue transglutaminase</entity> (<entity type=disease>tTG</entity>) antibodies, leading to inflammation and villous atrophy in the <entity type=disease>small intestine</entity> when <entity type=disease>gluten</entity> is consumed.\n```",
            " Text with markup:\n```\nThis results in <entity type=disease>malabsorption of nutrients</entity>, <entity type=disease>anemia</entity>, and other complications.\n```",
            " Text with markup:\n```\n<entity type=disease>NCGS</entity> does not involve an autoimmune response or intestinal damage, but still produces gastrointestinal symptoms such as bloating and <entity type=disease>abdominal pain</entity>.\n```",
            " Text with markup:\n```\nIn animals, <entity type=disease>NCGS</entity> has been observed in dogs, resulting in similar gastrointestinal distress, but it does not exhibit the same <entity type=disease>autoimmune pathology</entity> as seen in human <entity type=disease>NCGS</entity>.\n```",
            " Text with markup:\n```\nWhile patients with <entity type=disease>celiac disease</entity> require a strict <entity type=disease>gluten-free diet</entity> to prevent complications, individuals with <entity type=disease>NCGS</entity> often benefit from a gluten-reduced diet without the need for complete avoidance.\n```"
        ],
        "response_extract_mistral0.3": [
            " ```json:\n{\"diseases\": \"Celiac or Coeliac disease; non-celiac gluten sensitivity (NCGS)}\n```",
            " ```json:\n{\"diseases\": \"Celiac disease\"}\n```",
            " ```json:\n{\"diseases\": \"malabsorption; anemia\"}\n```",
            " ```json:\n{\"diseases\": \"NCGS; bloating; abdominal pain\"}\n```",
            " ```json:\n{\"diseases\": \"NCGS; gastrointestinal distress\"}\n```",
            " ```json:\n{\"diseases\": \"celiac disease; NCGS\"}\n```"
        ],
        "response_extract_rules_mistral0.3": [
            " ```json:\n{\"diseases\": \"Celiac or Coeliac disease; non-celiac gluten sensitivity (NCGS)\"}\n```",
            " ```json:\n{\"diseases\": \"Celiac disease\"}\n```",
            " ```json:\n{\"diseases\": \"malabsorption; anemia\"}\n```",
            " ```json:\n{\"diseases\": \"NCGS\"}\n```",
            " ```json:\n{\"diseases\": \"NCGS\"}\n```",
            " ```json:\n{\"diseases\": \"celiac disease; NCGS\"}\n```"
        ]
    }
}